These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15869571)

  • 1. Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? Yes.
    Scully MF
    J Thromb Haemost; 2005 May; 3(5):840-1. PubMed ID: 15869571
    [No Abstract]   [Full Text] [Related]  

  • 2. Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? No.
    Khamashta MA; Hunt BJ
    J Thromb Haemost; 2005 May; 3(5):844-5. PubMed ID: 15869573
    [No Abstract]   [Full Text] [Related]  

  • 3. Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? No.
    Rickles FR; Marder VJ
    J Thromb Haemost; 2005 May; 3(5):842-3. PubMed ID: 15869572
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral anticoagulation for the antiphospholipid antibody syndrome: can we now say less is more?
    Anderson DR
    J Thromb Haemost; 2005 May; 3(5):846-7. PubMed ID: 15869574
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recurrent thromboses and hemorrhagic complications in patients with antiphospholipid syndrome during therapy with warfarin plus aspirin].
    Kondrat'eva LV; Patrusheva NL; Patrushev LI; Aleksandrova EN; Kovalenko TF; Ostriakova EV; Reshetniak TM
    Ter Arkh; 2010; 82(5):33-9. PubMed ID: 20597268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS).
    Finazzi G; Marchioli R; Brancaccio V; Schinco P; Wisloff F; Musial J; Baudo F; Berrettini M; Testa S; D'Angelo A; Tognoni G; Barbui T
    J Thromb Haemost; 2005 May; 3(5):848-53. PubMed ID: 15869575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing oral anticoagulation requires expert experience and clinical evidence.
    Spyropoulos AC
    J Thromb Thrombolysis; 2006 Feb; 21(1):91-4. PubMed ID: 16475049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical inquiries. Does combining aspirin and warfarin decrease the risk of stroke for patients with nonvalvular atrial fibrillation?
    Robertson SL; Mayer JB; Guthmann R
    J Fam Pract; 2004 Jul; 53(7):570-5. PubMed ID: 15251100
    [No Abstract]   [Full Text] [Related]  

  • 9. Variability in the international normalised ratio (INR) in patients with antiphospholipid syndrome and positive lupus anticoagulant: should the INR targets be higher?
    Baquero-Salamanca M; Téllez-Arévalo AM; Calderon-Ospina C
    BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25858939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity of warfarin coagulation in the antiphospholipid syndrome.
    Crowther M; Crowther MA
    Curr Rheumatol Rep; 2010 Feb; 12(1):64-9. PubMed ID: 20425536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Warfarin in the treatment of antiphospholipid syndrome].
    Reshetniak TM; Kondrat'eva LV; Patrusheva NL; Patrushev LI
    Ter Arkh; 2007; 79(5):47-54. PubMed ID: 17672075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
    Bala MM; Celinska-Lowenhoff M; Szot W; Padjas A; Kaczmarczyk M; Swierz MJ; Undas A
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012169. PubMed ID: 33045766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of thrombosis during pregnancy.
    Vilela VS; de Jesús NR; Levy RA
    Isr Med Assoc J; 2002 Oct; 4(10):794-7. PubMed ID: 12389343
    [No Abstract]   [Full Text] [Related]  

  • 14. Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy.
    Pauzner R; Dulitzki M; Langevitz P; Livneh A; Kenett R; Many A
    Thromb Haemost; 2001 Dec; 86(6):1379-84. PubMed ID: 11776303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Not Available].
    Bauersachs R; Schellong S; Stücker M; Oldenburg J; Kalka C; Scholz U; Lindhoff-Last E
    Hamostaseologie; 2019 Aug; 39(3):298-300. PubMed ID: 31404932
    [No Abstract]   [Full Text] [Related]  

  • 16. [Aspirin and antiphospholipid syndrome].
    Hachulla E; Piette AM; Hatron PY; Blétry O
    Rev Med Interne; 2000 Mar; 21 Suppl 1():83s-88s. PubMed ID: 10763209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of recurrent thrombosis in the antiphospholipid antibody syndrome: how long and how high with oral anticoagulant therapy?
    Baker RI
    Med J Aust; 2004 May; 180(9):436-7. PubMed ID: 15115417
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence based treatment of the antiphospholipid syndrome II. Optimal anticoagulant therapy for thrombosis.
    Crowther MA; Wisloff F
    Thromb Res; 2005; 115(1-2):3-8. PubMed ID: 15567446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent venous thrombosis despite 'optimal anticoagulation therapy' for antiphospholipid syndrome--could new oral anticoagulants solve the problem?
    Balaban M; Stanrić V; Rincić G; Ledinsky M; Grbac L; Stancić N; Tomasić H
    Acta Clin Croat; 2010 Dec; 49(4):469-77. PubMed ID: 21830460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin prophylaxis in the antiphospholipid antibody syndrome.
    Stern SD
    N Engl J Med; 2003 Dec; 349(26):2568-70; author reply 2568-70. PubMed ID: 14699650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.